Why are so many of Lilly’s clinical trials now being run outside the United States?

We go outside the U.S. for speed and cost. Many countries let you enroll patients and get approvals faster while keeping high ethics and safety standards. U.S. trial infrastructure can be slower and pricier. We still run pivotal studies here, but we cannot ignore places that let us move faster without losing quality.